Garrison Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.37M | Sell |
26,314
-235
| -0.9% | -$19.8K | 1.2% | 33 |
|
|
2024
Q2 | $2.09M | Buy |
26,549
+119
| +0.5% | +$9.76K | 1.1% | 37 |
|
|
2024
Q1 | $2.3M | Sell |
26,430
-199
| -0.7% | -$17K | 1.21% | 33 |
|
|
2023
Q4 | $2.19M | Sell |
26,629
-369
| -1% | -$28.1K | 1.21% | 35 |
|
|
2023
Q3 | $2.12M | Buy |
26,998
+45
| +0.2% | +$3.77K | 1.29% | 35 |
|
|
2023
Q2 | $2.37M | Buy |
26,953
+506
| +2% | +$43.6K | 1.42% | 32 |
|
|
2023
Q1 | $2.13M | Sell |
26,447
-156
| -0.6% | -$12.7K | 1.32% | 35 |
|
|
2022
Q4 | $2.07M | Sell |
26,603
-149
| -0.6% | -$12.1K | 1.34% | 35 |
|
|
2022
Q3 | $2.16M | Sell |
26,752
-117
| -0.4% | -$10.5K | 1.53% | 25 |
|
|
2022
Q2 | $2.41M | Sell |
26,869
-152
| -0.6% | -$15.4K | 1.62% | 23 |
|
|
2022
Q1 | $3M | Buy |
27,021
+7
| +0% | +$740 | 1.69% | 24 |
|
|
2021
Q4 | $2.79M | Buy |
27,014
+455
| +2% | +$52.7K | 1.52% | 28 |
|
|
2021
Q3 | $3.33M | Buy |
26,559
+332
| +1% | +$43K | 2.02% | 19 |
|
|
2021
Q2 | $3.26M | Buy |
26,227
+227
| +0.9% | +$28.5K | 1.97% | 20 |
|
|
2021
Q1 | $3.07M | Buy |
26,000
+121
| +0.5% | +$14.2K | 1.95% | 21 |
|
|
2020
Q4 | $3.03M | Sell |
25,879
-12,003
| -32% | -$1.32M | 2.09% | 21 |
|
|
2020
Q3 | $3.94M | Buy |
37,882
+81
| +0.2% | +$8.13K | 2.08% | 20 |
|
|
2020
Q2 | $3.47M | Sell |
37,801
-147
| -0.4% | -$14.1K | 1.95% | 21 |
|
|
2020
Q1 | $3.42M | Sell |
37,948
-267
| -0.7% | -$28.4K | 2.31% | 18 |
|
|
2019
Q4 | $4.33M | Sell |
38,215
-469
| -1% | -$51.5K | 2.14% | 15 |
|
|
2019
Q3 | $4.2M | Sell |
38,684
-194
| -0.5% | -$20.2K | 2.18% | 14 |
|
|
2019
Q2 | $3.79M | Sell |
38,878
-236
| -0.6% | -$21.5K | 1.97% | 20 |
|
|
2019
Q1 | $3.56M | Buy |
39,114
+594
| +2% | +$53.2K | 1.88% | 20 |
|
|
2018
Q4 | $3.5M | Sell |
38,520
-349
| -0.9% | -$32.6K | 2.07% | 17 |
|
|
2018
Q3 | $3.82M | Sell |
38,869
-3,006
| -7% | -$278K | 1.89% | 22 |
|
|
2018
Q2 | $3.58M | Buy |
41,875
+2,548
| +6% | +$213K | 1.81% | 25 |
|
|
2018
Q1 | $3.15M | Buy |
39,327
+318
| +0.8% | +$26.2K | 1.77% | 26 |
|
|
2017
Q4 | $3.15M | Buy |
39,009
+801
| +2% | +$64.2K | 1.65% | 27 |
|
|
2017
Q3 | $2.97M | Buy |
38,208
+1,265
| +3% | +$105K | 1.67% | 27 |
|
|
2017
Q2 | $3.28M | Sell |
36,943
-217
| -0.6% | -$18.3K | 1.9% | 20 |
|
|
2017
Q1 | $2.99M | Buy |
37,160
+579
| +2% | +$45.2K | 1.76% | 26 |
|
|
2016
Q4 | $2.61M | Buy |
36,581
+547
| +2% | +$43K | 1.62% | 31 |
|
|
2016
Q3 | $3.11M | Buy |
36,034
+199
| +0.6% | +$17.3K | 2% | 21 |
|
|
2016
Q2 | $3.11M | Buy |
35,835
+1,414
| +4% | +$114K | 2.08% | 20 |
|
|
2016
Q1 | $2.58M | Sell |
34,421
-392
| -1% | -$29.5K | 1.81% | 29 |
|
|
2015
Q4 | $2.68M | Buy |
34,813
+785
| +2% | +$59.1K | 1.84% | 27 |
|
|
2015
Q3 | $2.28M | Buy |
34,028
+718
| +2% | +$52.9K | 1.66% | 31 |
|
|
2015
Q2 | $2.47M | Sell |
33,310
-187
| -0.6% | -$14.3K | 1.66% | 37 |
|
|
2015
Q1 | $2.61M | Buy |
+33,497
| New | +$2.54M | 1.73% | 31 |
|
Other funds holding MDT
Garrison Asset Management's MDT Position: Q3 2024 in Review
Garrison Asset Management reduced its Medtronic (MDT) stake by 0.89% in Q3 2024, selling an estimated $19.8K and leaving 26,314 shares worth $2.37M. The position accounts for 1.2% of the portfolio, ranked #33.
Garrison Asset Management first reported a position in MDT in Q1 2015 and has held it in 39 quarters since. The position peaked at $4.33M in Q4 2019. 2,064 funds tracked by Wall St. Rank hold MDT as of Q3 2024.
- Garrison Asset Management held 26,314 shares of Medtronic worth $2.37M as of Q3 2024.
- Garrison Asset Management sold 235 Medtronic shares in Q3 2024, an estimated $19.8K.
- Medtronic made up 1.2% of Garrison Asset Management's portfolio in Q3 2024, its #33 holding.
- Garrison Asset Management first reported a position in Medtronic in Q1 2015 and has held it in 39 quarters since.
- Garrison Asset Management's Medtronic position peaked at $4.33M in Q4 2019.
- 2,064 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.
Based on Garrison Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.